Marco Rosati

Dr. Marco Rosati

AstraZeneca Computational Pathology GmbH, Bernhard-Wicki-Straße 5, 80636 Munich, Germany
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2019 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
FLFriederike Liesche-Starnecker
Friederike Liesche-Starnecker
VRViktoria Ruf
Viktoria Ruf
SZSaida Zoubaa
Saida Zoubaa
GKGwendolyn Kaletka
Gwendolyn Kaletka
MRMarco Rosati
Marco Rosati
JSJürgen Schlegel
Jürgen Schlegel
After many years of controversy, there is now recent and solid evidence that classical Borna disease virus 1 (BoDV-1) can infect humans. On the basis of six brain autopsies, we provide the first systematic overview on BoDV-1 tissue distribution and the lesion pattern in fatal BoDV-1-induced encephalitis. All brains revealed a non-purulent, lymphocytic sclerosing panencephalomyelitis with detection of BoDV-1-typical eosinophilic, spherical intranuclear Joest–Degen inclusion bodies. While the composition of histopathological changes was constant, the inflammatory distribution pattern varied interindividually, affecting predominantly the basal nuclei in two patients, hippocampus in one patient, whereas two patients showed a more diffuse distribution. By immunohistochemistry and RNA in situ hybridization, BoDV-1 was detected in all examined brain tissue samples. Furthermore, infection of the peripheral nervous system was observed. This study aims at raising awareness to human bornavirus encephalitis as differential diagnosis in lymphocytic sclerosing panencephalomyelitis. A higher attention to human BoDV-1 infection by health professionals may likely increase the detection of more cases and foster a clearer picture of the disease.

1 August 2017 in Molecular Metabolism
Verified
Journal Article
Open access
ABAndreas Blutke
Andreas Blutke
SRSimone Renner
Simone Renner
FFFlorian Flenkenthaler
Florian Flenkenthaler
MBMattias Backman
Mattias Backman
SHSerena Haesner
Serena Haesner
EWEckhard Wolf
Eckhard Wolf
The prevalence of diabetes mellitus and associated complications is steadily increasing. As a resource for studying systemic consequences of chronic insulin insufficiency and hyperglycemia, we established a comprehensive biobank of long-term diabetic INSC94Y transgenic pigs, a model of mutant INS gene-induced diabetes of youth (MIDY), and of wild-type (WT) littermates. Female MIDY pigs (n = 4) were maintained with suboptimal insulin treatment for 2 years, together with female WT littermates (n = 5). Plasma insulin, C-peptide and glucagon levels were regularly determined using specific immunoassays. In addition, clinical chemical, targeted metabolomics, and lipidomics analyses were performed. At age 2 years, all pigs were euthanized, necropsied, and a broad spectrum of tissues was taken by systematic uniform random sampling procedures. Total beta cell volume was determined by stereological methods. A pilot proteome analysis of pancreas, liver, and kidney cortex was performed by label free proteomics. MIDY pigs had elevated fasting plasma glucose and fructosamine concentrations, C-peptide levels that decreased with age and were undetectable at 2 years, and an 82% reduced total beta cell volume compared to WT. Plasma glucagon and beta hydroxybutyrate levels of MIDY pigs were chronically elevated, reflecting hallmarks of poorly controlled diabetes in humans. In total, ∼1900 samples of different body fluids (blood, serum, plasma, urine, cerebrospinal fluid, and synovial fluid) as well as ∼17,000 samples from ∼50 different tissues and organs were preserved to facilitate a plethora of morphological and molecular analyses. Principal component analyses of plasma targeted metabolomics and lipidomics data and of proteome profiles from pancreas, liver, and kidney cortex clearly separated MIDY and WT samples. The broad spectrum of well-defined biosamples in the Munich MIDY Pig Biobank that will be available to the scientific community provides a unique resource for systematic studies of organ crosstalk in diabetes in a multi-organ, multi-omics dimension.

24 June 2014 in Brain Pathology
Verified
Journal Article
Closed access
PDF file
EWEva Wagner
Eva Wagner
MRMarco Rosati
Marco Rosati
JMJessica Molin
Jessica Molin
UFUlrike Foitzik
Ulrike Foitzik
AWAndrea M. Wahle
Andrea M. Wahle
KMKaspar Matiasek
Kaspar Matiasek

9 July 2020 in Genes
Verified
Journal Article
Open access
PDF file
JNJasmin Nicole
Jasmin Nicole
PHPetra Hug
Petra Hug
Paul J. J. MandigersPaul J. J. Mandigers
Paul J. J. Mandigers
PLPeter A. J. Leegwater
Peter A. J. Leegwater
VJVidhya Jagannathan
Vidhya Jagannathan
Tosso LeebTosso Leeb
Tosso Leeb
Four female Shetland Sheepdogs with hypertonic paroxysmal dyskinesia, mainly triggered by exercise and stress, were investigated in a retrospective multi-center investigation aiming to characterize the clinical phenotype and its underlying molecular etiology. Three dogs were closely related and their pedigree suggested autosomal dominant inheritance. Laboratory diagnostic findings included mild lactic acidosis and lactaturia, mild intermittent serum creatine kinase (CK) elevation and hypoglycemia. Electrophysiological tests and magnetic resonance imaging of the brain were unremarkable. A muscle/nerve biopsy revealed a mild type II fiber predominant muscle atrophy. While treatment with phenobarbital, diazepam or levetiracetam did not alter the clinical course, treatment with a gluten-free, home-made fresh meat diet in three dogs or a tryptophan-rich, gluten-free, seafood-based diet, stress-reduction, and acetazolamide or zonisamide in the fourth dog correlated with a partial reduction in, or even a complete absence of, dystonic episodes. The genomes of two cases were sequenced and compared to 654 control genomes. The analysis revealed a case-specific missense variant, c.1658G>A or p.Arg553Gln, in the PCK2 gene encoding the mitochondrial phosphoenolpyruvate carboxykinase 2. Sanger sequencing confirmed that all four cases carried the mutant allele in a heterozygous state. The mutant allele was not found in 117 Shetland Sheepdog controls and more than 500 additionally genotyped dogs from various other breeds. The p.Arg553Gln substitution affects a highly conserved residue in close proximity to the GTP-binding site of PCK2. Taken together, we describe a new form of paroxysmal exercise-induced dyskinesia (PED) in dogs. The genetic findings suggest that PCK2:p.Arg553Gln should be further investigated as putative candidate causal variant.

28 August 2015 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
KMKaspar Matiasek
Kaspar Matiasek
MPMartí Pumarola
Martí Pumarola
MRMarco Rosati
Marco Rosati
FFFrancisco Fernández-Flores
Francisco Fernández-Flores
AFAndrea Fischer
Andrea Fischer
HVHolger Volk
Holger Volk
Traditionally, histological investigations of the epileptic brain are required to identify epileptogenic brain lesions, to evaluate the impact of seizure activity, to search for mechanisms of drug-resistance and to look for comorbidities. For many instances, however, neuropathological studies fail to add substantial data on patients with complete clinical work-up. This may be due to sparse training in epilepsy pathology and or due to lack of neuropathological guidelines for companion animals. The protocols introduced herein shall facilitate systematic sampling and processing of epileptic brains and therefore increase the efficacy, reliability and reproducibility of morphological studies in animals suffering from seizures. Brain dissection protocols of two neuropathological centres with research focus in epilepsy have been optimised with regards to their diagnostic yield and accuracy, their practicability and their feasibility concerning clinical research requirements. The recommended guidelines allow for easy, standardised and ubiquitous collection of brain regions, relevant for seizure generation. Tissues harvested the prescribed way will increase the diagnostic efficacy and provide reliable material for scientific investigations.

1 December 2016 in Neuromuscular Disorders
Verified
Journal Article
Closed access
SGSimone Gross
Simone Gross
AFAndrea Fischer
Andrea Fischer
MRMarco Rosati
Marco Rosati
LMLara Matiasek
Lara Matiasek
DCDaniele Corlazzoli
Daniele Corlazzoli
KMKaspar Matiasek
Kaspar Matiasek